Endocrine and metabolic bone disorders Flashcards

1
Q

Briefly describe the composition of bone

A

Bone is generally comprised of a calcified matrix called osteoid, and three
types of bone cell, the osteoblasts, osteoclasts and osteocytes which continually synthesise and remodel the matrix.
- The organic part of the osteoid is almost entirely made of type 1 collagen, with the remaining 5% called ground substance being composed of proteoglycans.
- The complex hydroxyapatite crystals, which are comprised of hydrated calcium phosphate salts, form along
the collagen fibres. This hydroxyapatite provides the long-term storage
form of calcium and phosphate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Differentiate between woven and lamellar bone

A

Lamellar bone can be of the cortical (hard) or trabecular (spongy) type = has a regular parallel alignment of collagen (in alternating orientations) and is mechanically strong

Woven bone = disorganised collagen fibrils, weaker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why is it rickets in children and osteomalacia in adults?

A

RICKETS:
- affects cartilage of epiphysial growth plates and bone

OSTEOMALACIA:
- after epiphyseal closure, affects bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline the consequences impaired regulation of serum calcium and phosphate due to renal failure

A

Because the kidneys are the site of the enzyme that hydroxylates 25
hydroxycholecalciferol to produce calcitriol, renal impairment can result in
a deficiency of this enzyme. This will result in low levels of calcitriol, which in turn will cause secondary hyperparathyroidism. The renal impairment in addition means that there is a decreased excretion of phosphate, so that
a low blood level of calcium with a high level of phosphate can result. The
consequent effects of very high levels of PTH on the bone in this situation
mean that significant loss of bone can result => osteitis fibrosa cystica

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What can an elevated plasma phosphate concentration lead to?

A

vascular calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does Osteitis fibrosa cystica look like on x ray? Describe its treatment

A

Presents as ‘Brown tumours’ = radiolucent bone lesions

  • Treat the hyperphosphataemia with low phosphate diet and phosphate binders to reduce GI phosphate absorption
  • Give Alphacalcidol (i.e. calcitriol analogues)
  • Parathyroidectomy in tertiary hyperparathyroidism (hypercalcaemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Characterise osteoporosis.

A
  • Loss of bony trabeculae
  • Reduced bone mass
  • Weaker bone predisposed to fracture after minimal trauma
  • A feature of normal ageing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is osteoporosis diagnosed?

A

DEXA scan - femoral neck and lumbar spine; Mineral (calcium) content of bone measured.

Bone mineral density (BMD) > 2.5 standard deviations below the average value for young healthy adults (usually referred to as a T-score of -2.5 or lower)
BMD predicts future fracture risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Distinguish between osteoporosis and osteomalacia

A

OSTEOMALACIA:

  • Vitamin D deficiency (adults) causing inadequately mineralised bone
  • Serum biochemistry abnormal (low 25(OH) vit D, low Ca2+, high PTH (secondary hyperparathyroidism)

OSTEOPOROSIS

  • Bone reabsorption exceeds formation
  • Decreased bone MASS
  • Serum biochemistry normal
  • Diagnosis via DEXA scan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

State the pre-disposing conditions for osteoporosis

A
  • Postmenopausal oestrogen deficiency
  • Age-related deficiency in bone homeostasis (men and women) e.g. osteoblast senescence
  • Hypogonadism in young women and in men
  • Endocrine conditions e.g. Cushing’s syndrome, Hyperthyroidism, Primary hyperparathyroidism
  • Iatrogenic e.g. prolonged use of glucocorticoids, heparin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List the treatment options for osteoporosis

A
  1. Oestrogen/Selective Oestrogen Receptor Modulators
  2. Bisphosphonates (1st line)
  3. Denosumab (2nd line)
  4. Teriparatide (3rd line)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When treating post-menopausal osteoporosis with pharmacological doses of oestrogen, what are the considerations/limitations?

A

Women with an intact uterus need additional progestogen to prevent endometrial hyperplasia/cancer

Use limited largely due to concerns regarding:

  • Increased risk of breast cancer
  • Venous thromboembolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do bisphosphonates do?

A
  • Bind avidly to hydroxyapatite and ingested by osteoclasts => impaired ability of osteoclasts to reabsorb bone
  • Decrease osteoclast progenitor development and recruitment
  • Promote osteoclast apoptosis (programmed cell death)

Net result = reduced bone turnover

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the clinical uses of bisphosphonates, other than ostroporosis?

A

Malignancy:

  • associated hypercalcaemia
  • reduce bone pain from metastases

Paget’s disease
- reduce bony pain

Severe hypercalcaemic emergency (i.v. initially but +++ re-hydration first)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How are bisphosphonates administered? Where do they accumulate and for how long?

A

Orally active but poorly absorbed so take on an empty stomach (food, especially milk, reduces drug absorption generally)

Accumulates at site of bone mineralisation and remains part of bone until it is resorbed (after months or years)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Briefly summarise the 3 unwanted actions of bisphosphonates

A
  1. Oesophagitis
    - may require switch from oral to iv preparation
  2. Osteonecrosis of the jaw
    - greatest risk in cancer patients receiving iv bisphosphonates
  3. Atypical fractures
    - may reflect over-suppression of bone remodelling in prolonged bisphosphonate use
17
Q

What is denosumab and describe its mechanism of action, to include RoA + frequency

A

Human monoclonal antibody

  • Binds RANKL, inhibiting osteoclast formation and activity
  • Hence inhibits osteoclast-mediated bone resorption

RoA = SC injection 6/12 monthly

18
Q

What is teriparatide? What does it do? State the RoA + frequency

A

Recombinant PTH fragment (amino-terminal 34 amino acids of native PTH)

  • Increases bone formation and bone resorption, but formation outweighs resorption

RoA = Daily s.c. injection
£££

19
Q

Define Paget’s disease, outline the pathophysiology + epidemiology of the condition?

A

Accelerated, localised but disorganised bone remodelling

  • Characterised by excessive bone resorption (osteoclastic overactivity) followed by a compensatory increase in bone formation (osteoblasts)
  • New bone formed = WOVEN bone
  • Leads to bone frailty and bone hypertrophy + deformity

Epi facts:

  • Often positive family history
  • Highest in UK, N America, Australia and NZ; Lowest in Asian and Scandinavia
  • Men and women affected equally
  • Disease usually not apparent under age 50
  • Most patients are asymptomatic
20
Q

List the clinical features of Paget’ disease

A
  • Skull, thoracolumbar spine, pelvis, femur and tibia most commonly affected
  • Arthritis
  • Fracture
  • Pain
  • Bone deformity
  • Increased vascularity (warmth over affected bone)
  • Deafness – cochlear involvement
  • Radiculopathy – due to nerve compression
21
Q

How is Paget’s disease diagnosed?

A

Biochemical:

  • Plasma [Ca2+] normal
  • Plasma [alkaline phosphatase] usually increased

Plain X-rays:
- Lytic/bone lesions (early), thickened, enlarged, deformed bones (later)